BIA-Guided vs. Conventional Fluid Resuscitation in ICU Patients

Study acronym: BIA-FLUID
StatusActive, Not Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 7 months later Aug 15, 2026 → Apr 1, 2027
See other at-risk trials from Ondokuz Mayıs University

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Aug 15, 2026 to Apr 1, 2027 Show 7 more changesShow less
    • Start date changed from estimate of Sep 15, 2025 to Oct 1, 2026
    • Trial status changed: Not Yet Recruiting → Active, Not Recruiting
    • Study completion pushed from Dec 1, 2026 to May 1, 2027
    • Study sites: 0 to 1
    • Eligibility criteria expanded, about 9 words
    • Secondary endpoints: details revised at 3 of 5 entries
    • Publications: details revised at 4 of 4 entries
  2. Notable Start date: Aug 15, 2025 to Sep 15, 2025v2
  3. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
In this study aimed to compare bioelectrical impedance analysis (BIA)-guided fluid resuscitation with conventional fluid management strategies in patients admitted to the intensive care unit (ICU) following major surgery. The primary objective is to evaluate whether BIA-guided fluid therapy reduces 28-day mortality by optimizing fluid balance and preventing volume-related complications. Secondary outcomes include cumulative fluid balance, ICU and hospital length of stay, duration of mechanical ventilation, and need for vasopressor or inotropic support. This study is expected to provide evidence for the clinical utility and applicability of BIA in guiding postoperative fluid therapy in critically ill patients.
Trial Details
NCT Number NCT07142083
Lead Sponsor Ondokuz Mayıs University
Conditions
(from sponsor)
Fluid and Electrolyte Imbalance, Anesthesia
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov